Skip to main content

Why pay full price for medications?

See Prices Now

What side effects are reported with Retatrutide?

Retatrutide is a once-weekly injectable medication developed by Eli Lilly that has shown promise in the treatment of obesity and type 2 diabetes. It works on 3 receptors that are involved in glucose metabolism and appetite regulation: glucagon-like peptide-1 (GLP-1) receptor, glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. The common side effects reported are similar to GLP-1 agonists, and include nausea, vomiting, diarrhea, abdominal discomfort, bloating, and constipation. There were reports that some people experienced a slight increase in their heart rate, which has also been seen with GLP-1 agonists. However, because of its unique mechanism of action, further research is needed to see what other side effects are possible.

Shop Medications

Why Pay Full Price?

Search our full medication catalogue and save up to 80% - no insurance needed.

See Prices Now

Related Conditions